Date Filed | Type | Description |
12/08/2017 |
4
| OAKLEY ROBERT A (Director) has filed a Form 4 on PharMerica CORP
Txns:
| Disposed/sold 57,275 shares
@ $29.25, valued at
$1.7M
|
|
06/16/2017 |
4
| OAKLEY ROBERT A (Director) has filed a Form 4 on PharMerica CORP
Txns:
| Granted 4,817 shares
@ $0 |
|
06/21/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/23/2015 |
4
| OAKLEY ROBERT A (Director) has filed a Form 4 on PharMerica CORP
Txns:
| Granted 3,730 shares
@ $0 |
|
08/12/2014 |
4
| OAKLEY ROBERT A (Director) has filed a Form 4 on PharMerica CORP
Txns:
| Sold 8,399 shares
@ $26.551, valued at
$223k
Exercised 13,600 options to buy
@ $16.16, valued at
$219.8k
|
|
06/18/2014 |
4
| OAKLEY ROBERT A (Director) has filed a Form 4 on PharMerica CORP
Txns:
| Granted 4,300 shares
@ $0 |
|
07/03/2013 |
4/A
| OAKLEY ROBERT A (Director) has filed a Form 4 on PharMerica CORP
Txns:
| Granted 5,556 shares
@ $0 |
|
06/19/2013 |
4
| OAKLEY ROBERT A (Director) has filed a Form 4 on PharMerica CORP
Txns:
| Granted 5,685 shares
@ $0 |
|
06/14/2013 |
4
| OAKLEY ROBERT A (Director) has filed a Form 4 on PharMerica CORP
Txns:
| Paid exercise price by delivering 3,300 shares
@ $15.5, valued at
$51.2k
|
|
09/27/2012 |
4
| OAKLEY ROBERT A (Director) has filed a Form 4 on PharMerica CORP
Txns:
| Disposed/sold 2,500 shares
@ $12.68, valued at
$31.7k
|
|
06/13/2012 |
4
| OAKLEY ROBERT A (Director) has filed a Form 4 on PharMerica CORP
Txns:
| Granted 9,657 shares
@ $0 |
|
06/13/2011 |
4
| OAKLEY ROBERT A (Director) has filed a Form 4 on PharMerica CORP
Txns:
| Granted 7,273 shares
@ $0 |
|
08/26/2010 |
4/A
| OAKLEY ROBERT A (Director) has filed a Form 4 on PharMerica CORP
Txns:
| Bought 3,000 shares
@ $7.699, valued at
$23.1k
|
|
08/17/2010 |
4
| OAKLEY ROBERT A (Director) has filed a Form 4 on PharMerica CORP
Txns:
| Granted 3,000 shares
@ $7.699, valued at
$23.1k
|
|
05/28/2010 |
4
| OAKLEY ROBERT A (Director) has filed a Form 4 on PharMerica CORP
Txns:
| Granted 4,893 shares
@ $0 |
|
06/08/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |